Texas Cardiac Arrhythmia Research Foundation

Closed portfolio with a later-stage archive tilt

According to ClinicalTrials.gov-derived indexes, Texas Cardiac Arrhythmia Research Foundation sits in the top decile of US sponsors by registered trial count (#934 of 15,742 sponsors by registered trial count).

15 total trials none currently recruiting 14 completed later-stage tilt top decile by trial count

Texas Cardiac Arrhythmia Research Foundation: 15 sponsored US clinical trials, none currently recruiting.

Texas Cardiac Arrhythmia Research Foundation sponsors 15 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 14 completed. 9 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Atrial Fibrillation, with 3 trials.

Top-decile sponsor footprint

Texas Cardiac Arrhythmia Research Foundation ranks in the top decile of sponsors by registered trial count (#934 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 73/100

14 of 15 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (93.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

15 total, page 1 of 1

TERMINATED

Safety and Efficacy of Pulsed-field Ablation for Atrial Fibrillation in High Versus Low-volume Ablation Centers (SAFFICIENT)

NCT06488820
COMPLETED NA

Half-normal Saline in Atrial Fibrillation Ablation

NCT03498586
COMPLETED

Role of Cardiac Biomarkers in Prediction of Outcome in Atrial Fibrillation Patients Undergoing Catheter Ablation

NCT02208102
COMPLETED Phase 3

Outcome of Different Ablation Strategies In Persistent and Long-Standing Persistent Atrial Fibrillation

NCT02533843
COMPLETED

Determining the Association of Chromosomal Variants With Non-PV Triggers and Ablation-outcome in AF (DECAF)

NCT01751607
COMPLETED NA

Outcome of Atrial Fibrillation Ablation After Permanent Pulmonary Vein Antrum Isolation With or Without Proven Left Atrial Posterior Wall Isolation

NCT01660100
COMPLETED Phase 3

Impact Of Different Ablation Approaches on Outcome In Coexistent Atrial Fibrillation and Flutter

NCT01439386
COMPLETED Phase 3

Effect of Catheter Ablation on Clinical Course of Migraine in AF Patients With or Without Previous History of Migraine

NCT01391091
COMPLETED Phase 3

Effect of Empirical Left Atrial Appendage Isolation on Long-term Procedure Outcome in Patients With Persistent or Long-standing Persistent Atrial Fibrillation Undergoing Catheter Ablation

NCT01362738
COMPLETED Phase 3

Effect of Amiodarone on the Procedure Outcome in Long-standing Persistent Atrial Fibrillation Undergoing Pulmonary Vein Antral Isolation

NCT01173809
COMPLETED

The Role of Cardiac Biomarkers in Prediction of Outcome in Atrial Fibrillation Patients Undergoing Catheter Ablation

NCT01148914
COMPLETED Phase 3

Ablation of Perimitral Flutter Following Catheter Ablation of Atrial Fibrillation: Impact on Outcomes

NCT01173796
COMPLETED Phase 3

Ablation of Clinical Ventricular Tachycardia Versus Addition of Substrate Ablation on the Long Term Success Rate of VT Ablation

NCT01045668
COMPLETED Phase 3

Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation

NCT01006876
COMPLETED Phase 4

Ablation vs Amiodarone for Treatment of AFib in Patients With CHF and an ICD

NCT00729911

Phase Distribution

PhaseTrial count
Phase 3 8
Phase 4 1

Therapeutic Areas

Atrial Fibrillation 3
Ventricular Tachycardia 1
Migraine 1
Heart Failure 1

How the Texas Cardiac Arrhythmia Research Foundation archive is shaped

15 indexed studies, none listed as recruiting (0% open); 14 completed (93%).

Phase mix: 9 late (III/IV) vs 0 early (I/II) (later-stage heavy).

Top condition: Atrial Fibrillation (3 trials), 3 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Texas Cardiac Arrhythmia Research Foundation: archived-pipeline peers nationwide

Peers matched on 15 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Texas Cardiac Arrhythmia Research Foundation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05101520 0%10%20%30%40% Total trials Recruiting share Texas Cardiac Arrhythmia Research FoundationAllakosArbor Research Collaborative for HealthArena PharmaceuticalsArrowhead Pharmaceuticals10xBio22nd Century Group23andMe3-C Institute for Social Development
Texas Cardiac Arrhythmia Research Foundation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Texas Cardiac Arrhythmia Research Foundation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 15 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Texas Cardiac Arrhythmia Research Foundation page

15 registered trials is a research-attention snapshot, not an endorsement of Texas Cardiac Arrhythmia Research Foundation or any single study.

  • None of Texas Cardiac Arrhythmia Research Foundation's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Atrial Fibrillation is the condition Texas Cardiac Arrhythmia Research Foundation studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Atrial Fibrillation trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Texas Cardiac Arrhythmia Research Foundation pipeline card: 15 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.